Spondyloarthritis (SpA) is a disease that normally affects the axial skeleton. It progressively leads to overall stiffness up to severe postural deformity of rachis and functional impotence. The objective of the study was to quantify, through an economic model, the impact of specialized testing and pharmacological treatments carried out by the National Health Service (NHS) in normal clinical practice, before the patient is diagnosed with SpA in Italy. In line with the analysis objective, the chosen perspective is that of the NHS.
Mennini, F.s., Viti, R., Marcellusi, A., Sciattella, P., Viapiana, O., Rossini, M. (2018). Economic evaluation of spondyloarthritis: Economic impact of diagnostic delay in Italy. CLINICOECONOMICS AND OUTCOMES RESEARCH, 10, 45-51 [10.2147/CEOR.S144209].
Economic evaluation of spondyloarthritis: Economic impact of diagnostic delay in Italy
Mennini F. S.
Methodology
;Sciattella P.Data Curation
;Rossini M.
2018-01-01
Abstract
Spondyloarthritis (SpA) is a disease that normally affects the axial skeleton. It progressively leads to overall stiffness up to severe postural deformity of rachis and functional impotence. The objective of the study was to quantify, through an economic model, the impact of specialized testing and pharmacological treatments carried out by the National Health Service (NHS) in normal clinical practice, before the patient is diagnosed with SpA in Italy. In line with the analysis objective, the chosen perspective is that of the NHS.| File | Dimensione | Formato | |
|---|---|---|---|
|
2018_spondiloartrite_CEOR-144209-economic-evaluation-of-spondyloarthritis--economic-impact-of_010918.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
405.48 kB
Formato
Adobe PDF
|
405.48 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
